2001 International Conference of the American Thoracic Society,
San Francisco, CA. May 2001.
Ajayi A, Jedlovszky V, Salazar-Schicchi
J, Colson PW, Hirsch-Moverman Y, Bower BL, El-Sadr W.
Physician attitudes toward the role of BCG vaccination &
treatment for Latent Tuberculosis Infection (LTBI) (CDC poster
To investigate the attitudes of physicians-in-training on
prevention and treatment of latent tuberculosis infection.
Physicians trained in other countries may hold attitudes inconsistent
with US practices.
Methods: An anonymous
survey was distributed among medical house-staff in an inner-city
teaching hospital. Questions included participant characteristics:
age, gender, level of training, place of primary medical training,
history of BCG, and PPD status. Assessment of attitudes included
questions on protective effect of BCG and LTBI treatment.
Scenarios were constructed to test respondents' attitudes
toward the need for LTBI treatment for BCG-vaccinated persons
with positive PPD. These included a recent immigrant, an HIV+
patient, a patient without these risk factors, a family member,
All participants were foreign medical graduates. Of 77 participants,
72.4% were male, mean age was 31.4, mean years post-graduation
8.0 (range 3-18), mean years practiced in US 2.0 (range 0-7).
62.7% were PPD+ and 88.3% received BCG vaccine. Regarding
attitudes, most (66.2%) believed that BCG offers protection
for a short time. Only 57.9% believed that LTBI treatment
offers protection against TB and 16.0% felt that LTBI treatment
involved more risks than benefits. With the scenarios, most
recommended LTBI treatment for BCG-vaccinated patients with
positive PPDs (67.1 - 96.1%), with less support for treating
family (55.6%) and themselves (49.3%). For recent converters,
more than 80% recommended LTBI treatment under all scenarios.
Foreign-trained physicians are cautious about prescribing
LTBI treatment except for recent converters. They are less
likely to prescribe medications for themselves and family
than for others. Education should focus on physician attitudes
regarding LTBI treatment and BCG.